Literature DB >> 25047824

Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.

Abdirisak Ahmed Haji Omar1, Johanna Korvala, Caj Haglund, Susanna Virolainen, Valtteri Häyry, Timo Atula, Risto Kontio, Jarmo Rihtniemi, Antti Pihakari, Timo Sorsa, Jaana Hagström, Tuula Salo.   

Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC) has a worse prognosis than cutaneous squamous cell carcinoma (CSCC). Toll-like receptor- 4 (TLR-4) and TLR-5 are transmembrane proteins that recognize endogenous and microbial agents. Their activation has been connected to cancer invasion.
OBJECTIVE: The aim was to study the expression of TLR-4 and TLR-5 in OSCC and CSCC samples, and the effects of TLR-5 ligand flagellin on the proliferation, migration, and invasion of different mucocutaneous cell lines in vitro.
METHODS: Samples of early-stage tumors (T1-T2N0M0) from 63 patients with OSCC and CSCC were obtained, in addition to eight normal mucosa and skin tissues from healthy subjects. Oral-cavity-derived highly aggressive HSC-3, less invasive SAS, and HPV-transformed benign IHGK as well as C-ha-ras-transformed (HaCat) skin carcinoma II-4 and non-invasive A5 cell lines were used. Flagellin-induced mucocutaneous cell lines were compared by using BrdU-proliferation, scratch migration, and myoma organotypic invasion assays.
RESULTS: TLR-4 expression was similar in OSCC and CSCC tumors. TLR-5 was more abundant in OSCC than in CSCC samples. Flagellin induced the proliferation of SAS, II-4 and A5, migration of IHGK, II-4 and A5, and the invasion of II-4 cells. It had no effect on HSC-3 cells.
CONCLUSIONS: Flagellin, a TLR-5 agonist, induced the migration and invasion of less aggressive mucocutaneous cell lines, but it had no effect on the most invasive oral carcinoma cells. The more aggressive clinical behavior of OSCC compared to CSCC may partially be related to the differences in the expression of TLR-5 in these malignancies.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  oral cancer; skin cancer; toll-like receptors

Mesh:

Substances:

Year:  2014        PMID: 25047824     DOI: 10.1111/jop.12233

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  10 in total

1.  Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.

Authors:  K Hirvonen; L Bäck; C Haglund; I Leivo; L Jouhi; A A Mäkitie; J Hagström
Journal:  Tumour Biol       Date:  2016-02-18

2.  Targeting Toll-Like Receptors for Cancer Therapy.

Authors:  Marc J Braunstein; John Kucharczyk; Sylvia Adams
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

3.  Diagnostic model of saliva peptide finger print analysis of oral squamous cell carcinoma patients using weak cation exchange magnetic beads.

Authors:  Wei-Peng Jiang; Zhen Wang; Li-Xin Xu; Xin Peng; Feng Chen
Journal:  Biosci Rep       Date:  2015-05-12       Impact factor: 3.840

4.  Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma.

Authors:  Miia Ruuskanen; Ilmo Leivo; Heikki Minn; Tero Vahlberg; Caj Haglund; Jaana Hagström; Heikki Irjala
Journal:  BMC Cancer       Date:  2019-06-25       Impact factor: 4.430

5.  Role of Toll like receptor in progression and suppression of oral squamous cell carcinoma.

Authors:  Yash Sharma; Kumud Bala
Journal:  Oncol Rev       Date:  2020-05-19

6.  A novel human leiomyoma tissue derived matrix for cell culture studies.

Authors:  Tuula Salo; Meeri Sutinen; Ehsanul Hoque Apu; Elias Sundquist; Nilva K Cervigne; Carine Ervolino de Oliveira; Saad Ullah Akram; Steffen Ohlmeier; Fumi Suomi; Lauri Eklund; Pirjo Juusela; Pirjo Åström; Carolina Cavalcante Bitu; Markku Santala; Kalle Savolainen; Johanna Korvala; Adriana Franco Paes Leme; Ricardo D Coletta
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

7.  The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer.

Authors:  Heikki Huhta; Olli Helminen; Joonas H Kauppila; Tuula Salo; Katja Porvari; Juha Saarnio; Petri P Lehenkari; Tuomo J Karttunen
Journal:  J Histochem Cytochem       Date:  2016-07-01       Impact factor: 2.479

Review 8.  Organotypic three-dimensional assays based on human leiomyoma-derived matrices.

Authors:  Tuula Salo; Mauricio Rocha Dourado; Elias Sundquist; Ehsanul Hoque Apu; Ilkka Alahuhta; Katja Tuomainen; Jenni Vasara; Ahmed Al-Samadi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 9.  Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.

Authors:  Yazdan Mokhtari; Atieh Pourbagheri-Sigaroodi; Parisa Zafari; Nader Bagheri; Seyed H Ghaffari; Davood Bashash
Journal:  J Cell Mol Med       Date:  2020-12-18       Impact factor: 5.295

Review 10.  Microbial Colonization and Inflammation as Potential Contributors to the Lack of Therapeutic Success in Oral Squamous Cell Carcinoma.

Authors:  Zoya Kurago; Jenni Loveless
Journal:  Front Oral Health       Date:  2021-10-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.